Filomena Russo
University of Siena
Repeated measures designPsychiatryOpticsBiophysicsInternal medicineCalcineurinPsychologyAntibodyDermatologyMonoclonalData managementRetrospective cohort studySocial distanceWorkflowIntensive care medicineTumor necrosis factor alphaPediatricsMaterials scienceMedical physicsAdverse effectYoung adultIn vivoMultidisciplinary approachHidradenitis suppurativaNail (anatomy)Dermatology Life Quality IndexTeledermatologyPittsburgh Sleep Quality IndexPrurigo nodularisDiscoid lupus erythematosusCyclophosphamideAzathioprineCombination therapyPsoriasis Area and Severity IndexReticular erythematous mucinosisBody surface areaRett syndromeDapsoneGuselkumabNeurofibromaAmenorrheaTimololAtopic dermatitisTolerabilityAcitretinDiscontinuationUstekinumabNeurofibromatosisHydroxychloroquineDiseaseMEDLINEVismodegibIxekizumabSecukinumabDupilumabChronic inflammatory demyelinating polyneuropathyExtracorporealItchingDrugContext (language use)GranulomaPyoderma gangrenosumPsoriasisRituximabEczema Area and Severity IndexAlcohol Use Disorders Identification TestPyogenic granulomaPathogenesisMethotrexatePrurigoSuspicious for MalignancyPopulationVulvar neoplasmAdrenergic beta-AntagonistsAdult atopic dermatitisExtracorporeal PhotopheresisAcquired hemophiliaMultifactorial InheritanceGORLIN-GOLTZ SYNDROMEDigital analysisReflectance confocal microscopyManagement modelSkin lesionDiagnostic algorithmsSocial lifeClinical evidenceSeverity of illnessDiagnosis treatmentNew onsetDisease severityIn patientFemale adolescentComplex diseaseWaiting timeModerate to severe psoriasisAfter treatmentFemale patientPreviously treatedTotal hip replacementFuture perspectivePlaque psoriasisObjectivity (science)Substance abuseIncidence (epidemiology)RefractoryInterleukin 17NecrosisMedical educationDelphi methodIntervention (law)Genetic predispositionText miningMedicineCohortRating scaleAnalysis of variance
26Publications
2H-index
30Citations
Publications 28
Newest
#1Emanuele Trovato (UNISI: University of Siena)H-Index: 1
#2Giulio Cortonesi (UNISI: University of Siena)H-Index: 1
Last. Pietro Rubegni (UNISI: University of Siena)H-Index: 32
view all 7 authors...
Source
#1Nicola Milanesi (UniFI: University of Florence)H-Index: 6
#2Massimo Gola (UniFI: University of Florence)H-Index: 13
Last. Filomena Russo (UNISI: University of Siena)H-Index: 2
view all 8 authors...
BACKGROUND Sleep disturbances are common in patients with atopic dermatitis (AD). Considering their relevant burden on health, routine screening of sleep disturbances seems to be very useful in AD adults management. However, few studies have evaluated the association between sleep disturbances and AD in adults and real-life data are lacking. The aim is to assess the effect of treatment with dupilumab on sleep disturbances in adult patients with severe atopic dermatitis. METHODS Retrospective, mu...
Source
#1Nicola Milanesi (Health Science University)
#2Greta Tronconi (Health Science University)
Last. Filomena Russo (UNISI: University of Siena)H-Index: 2
view all 5 authors...
Source
#1Filomena Russo (UNISI: University of Siena)H-Index: 2
#2Francesco Bruzziches (UNISI: University of Siena)
Last. Pietro Rubegni (UNISI: University of Siena)H-Index: 32
view all 8 authors...
Source
#1Filomena Russo (UNISI: University of Siena)H-Index: 2
#2Virginia Mancini (UNISI: University of Siena)H-Index: 4
Last. Elisa Cinotti (UNISI: University of Siena)H-Index: 18
view all 7 authors...
Source
#1Antonio Costanzo (Humanitas University)H-Index: 61
#2Filomena RussoH-Index: 2
view all 33 authors...
Secukinumab, a fully human monoclonal antibody, neutralizes interleukin-17A, a cornerstone cytokine driving the multiple manifestations of psoriasis. This post-hoc analysis of the SUPREME study was performed to determine the sustainability of response to secukinumab in terms of Psoriasis Area and Severity Index (PASI) 90 in patients with moderate-to-severe plaque psoriasis. Based on PASI 90 response at week 16, patients were stratified as PASI 90 responders (PASI90R, n = 337) or non-responders (...
Source
#1Linda Tognetti (UNISI: University of Siena)H-Index: 11
#2Diletta Fiorani (UNISI: University of Siena)H-Index: 4
Last. Pietro Rubegni (UNISI: University of Siena)H-Index: 32
view all 9 authors...
Born in 1995, teledermatology (TD) turns 25 years old today. Since then, TD evolved according to patients and physicians needs. The present review aimed to summarize all the efforts and experiences carried out in the field of TD and its subspecialties, the evolution and the future perspectives. A literature search was conducted in PubMed and Google Scholar. The state of the art of the "tele-dermo research" included TD and clinical trials, TD/TDS web platforms, TDS and artificial intelligence stu...
Source
#1Filomena RussoH-Index: 2
Last. Pietro RubegniH-Index: 32
view all 9 authors...
Source
#1Emanuele Trovato (UNISI: University of Siena)H-Index: 1
#2Corinne Orsini (UNISI: University of Siena)
Last. Pietro Rubegni (UNISI: University of Siena)H-Index: 32
view all 5 authors...
Erytrhodermic psoriasis (EP) is a rare subset of psoriasis that is considered a dermatologic emergency. Due to its limited clinical evidence, pathogenesis is largely unknown and its treatment represents a challenge. Conventional therapies such as methotrexate, cyclosporine and acitretin are still considered first-line of treatment but it is necessary to study the efficacy and safety of biologics, including anti-tumor necrosis factor (TNF), anti-interleukin (IL)-23 and anti-IL17 agents to define ...
1 CitationsSource
#1Filomena Russo (UNISI: University of Siena)H-Index: 2
#2Martina VispiH-Index: 2
Last. Michele Pellegrino (UNISI: University of Siena)H-Index: 11
view all 7 authors...
1 CitationsSource